Graham Capital Management, L.P. G1 Therapeutics, Inc. Transaction History

Graham Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $79,072 - $178,991	35,942 Added 186.46%	55,218 $125,000
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $40,479 - $93,103	19,276 New	19,276 $83,000
Q2 2023 Aug 14, 2023	BUY	$2.46 - $3.14 $137,280 - $175,227	55,805 New	55,805 $138,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $487,737 - $1.6 Million	94,340 New	94,340 $1.18 Million
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $63,593 - $133,955	-15,741 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.6 - $11.02 $119,631 - $173,465	15,741 New	15,741 $119,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.